Nippon India Nifty Pharma ETF - Growth Plan vs Axis Equity Etfs FOF Direct Growth
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Axis Equity Etfs FOF Direct Growth | |
|---|---|---|
| NAV | ₹27.1122 | ₹15.8505 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +5.09% |
| 3 year (p.a.) | +20.35% | +10.58% |
| 5 year (p.a.) | +14.55% | +10.84% |
| Expense ratio | 0.18% | 0.08% |
| Fund size | ₹1,622.31 Cr | ₹36.03 Cr |
| Risk | Very high | Very high |
| Category | Etfs | Fund of Funds Domestic Equity |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.